University research records
Zaporizhzhia State Medical and Pharmaceutical University
5 imported, source-linked research records. Published in the last five years.
Published in the last five years
Back to university profile →5 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Zaporizhzhia State Medical and Pharmaceutical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–5 of 5 matching records. Counts update as records arrive.
The Influence of Basic Therapy and New Drugs on NO-Dependent Mechanisms of Cardiac Destruction in Chronic Heart Failure
April 30, 2026 · 1 citations · Open access
Open original record →Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure
November 8, 2023 · 12 citations · Open access
Open original record →The effect of sglt-2 inhibitor dapagliflozin on adropin serum levels in patients with chronic heart failure and concomitant type 2 diabetes mellitus
November 1, 2023 · 0 citations · Open access
Open original record →The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
February 4, 2023 · 18 citations · Open access
Open original record →The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
July 20, 2022 · 16 citations · Open access
Open original record →